164 related articles for article (PubMed ID: 2566926)
1. Biphasic relaxant curves to glyceryl trinitrate in rat aortic rings. Evidence for two mechanisms of action.
Malta E
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):236-43. PubMed ID: 2566926
[TBL] [Abstract][Full Text] [Related]
2. Studies on the biphasic relaxant curve of glyceryl trinitrate in rat aorta: role of GTN metabolites.
Malta E
Clin Exp Pharmacol Physiol; 1989 Nov; 16(11):829-35. PubMed ID: 2515014
[TBL] [Abstract][Full Text] [Related]
3. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
Yu SM; Kuo SC
Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
[TBL] [Abstract][Full Text] [Related]
4. Relationship between cyclic guanosine monophosphate accumulation and relaxation of canine trachealis induced by nitrovasodilators.
Zhou HL; Torphy TJ
J Pharmacol Exp Ther; 1991 Sep; 258(3):972-8. PubMed ID: 1679854
[TBL] [Abstract][Full Text] [Related]
5. Modification by LY 83583 and methylene blue of relaxation induced by nitric oxide, glyceryl trinitrate, sodium nitroprusside and atriopeptin in aortae of the rat, guinea-pig and rabbit.
Kawada T; Ishibashi T; Sasage H; Kato K; Imai S
Gen Pharmacol; 1994 Nov; 25(7):1361-71. PubMed ID: 7896047
[TBL] [Abstract][Full Text] [Related]
6. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.
Delpy E; Coste H; Gouville AC
Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of vascular smooth muscle relaxation by LY83583.
Malta E; Macdonald PS; Dusting GJ
Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):459-64. PubMed ID: 2900475
[TBL] [Abstract][Full Text] [Related]
8. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
Komas N; Lugnier C; Stoclet JC
Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of NO-medicate responses by 7-ethoxyresorufin, a substrate and competitive inhibitor of cytochrome P450.
Li CG; Rand MJ
Br J Pharmacol; 1996 May; 118(1):57-62. PubMed ID: 8733576
[TBL] [Abstract][Full Text] [Related]
10. Involvement of charybdotoxin-sensitive K+ channel in the relaxation of bovine tracheal smooth muscle by glyceryl trinitrate and sodium nitroprusside.
Hamaguchi M; Ishibashi T; Imai S
J Pharmacol Exp Ther; 1992 Jul; 262(1):263-70. PubMed ID: 1378093
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor.
Merkel LA; Rivera LM; Perrone MH; Lappe RW
Eur J Pharmacol; 1992 May; 216(1):29-35. PubMed ID: 1326438
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of nitrovasodilator- and acetylcholine-induced relaxation and cyclic GMP accumulation by the cytochrome P-450 substrate, 7-ethoxyresorufin.
Bennett BM; McDonald BJ; Nigam R; Long PG; Simon WC
Can J Physiol Pharmacol; 1992 Sep; 70(9):1297-303. PubMed ID: 1362924
[TBL] [Abstract][Full Text] [Related]
13. Effects of atrial natriuretic factor, sodium nitroprusside, and acetylcholine on cyclic GMP levels and relaxation in rat aorta.
Rapoport RM; Waldman SA; Schwartz K; Winquist RJ; Murad F
Eur J Pharmacol; 1985 Sep; 115(2-3):219-29. PubMed ID: 2998822
[TBL] [Abstract][Full Text] [Related]
14. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
[TBL] [Abstract][Full Text] [Related]
15. Contribution of K+ channels and ouabain-sensitive mechanisms to the endothelium-dependent relaxations of horse penile small arteries.
Prieto D; Simonsen U; Hernández M; García-Sacristán A
Br J Pharmacol; 1998 Apr; 123(8):1609-20. PubMed ID: 9605568
[TBL] [Abstract][Full Text] [Related]
16. The relaxant effect of glyceryltrinitrate on isolated human peripheral vein and its relation to cyclic GMP metabolism.
Ahlner J; Andersson RG; Axelsson KL; Bergdahl B; Dahlström U; Rydell EL
Acta Pharmacol Toxicol (Copenh); 1986 Feb; 58(2):129-36. PubMed ID: 2871692
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
Delpy E; le Monnier de Gouville AC
Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060
[TBL] [Abstract][Full Text] [Related]
18. Conversion of glyceryl trinitrate to nitric oxide in tolerant and non-tolerant smooth muscle and endothelial cells.
Salvemini D; Pistelli A; Vane J
Br J Pharmacol; 1993 Jan; 108(1):162-9. PubMed ID: 8381319
[TBL] [Abstract][Full Text] [Related]
19. Contribution of activation of K+ channels to glyceryl trinitrate-induced relaxation of rabbit aorta.
Ishibashi T; Kawada T; Kato K; Hamaguchi M; Imai S
Gen Pharmacol; 1995 May; 26(3):543-52. PubMed ID: 7540579
[TBL] [Abstract][Full Text] [Related]
20. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
Yu SM; Cheng ZJ; Kuo SC
Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
